Cargando…

A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player

Radiotherapy, along with other loco-regional interventions, is conventionally utilized as a palliative approach to alleviate symptoms and mitigate oncological emergencies in advanced non-small cell lung cancer (NSCLC). Thanks to the ongoing improvement of medical treatments in the last decade, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yue, Yu, Fan, Zhao, Yang, Zeng, Ya, Yang, Xi, Chu, Li, Chu, Xiao, Li, Yida, Zou, Liqing, Guo, Tiantian, Zhu, Zhengfei, Ni, Jianjiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815368/
https://www.ncbi.nlm.nih.gov/pubmed/33489808
http://dx.doi.org/10.21037/tlcr-20-1145
_version_ 1783638215262994432
author Zhou, Yue
Yu, Fan
Zhao, Yang
Zeng, Ya
Yang, Xi
Chu, Li
Chu, Xiao
Li, Yida
Zou, Liqing
Guo, Tiantian
Zhu, Zhengfei
Ni, Jianjiao
author_facet Zhou, Yue
Yu, Fan
Zhao, Yang
Zeng, Ya
Yang, Xi
Chu, Li
Chu, Xiao
Li, Yida
Zou, Liqing
Guo, Tiantian
Zhu, Zhengfei
Ni, Jianjiao
author_sort Zhou, Yue
collection PubMed
description Radiotherapy, along with other loco-regional interventions, is conventionally utilized as a palliative approach to alleviate symptoms and mitigate oncological emergencies in advanced non-small cell lung cancer (NSCLC). Thanks to the ongoing improvement of medical treatments in the last decade, such as targeted therapy and immunotherapy, the survival of patients with advanced NSCLC has been considerably prolonged, making it feasible and clinically beneficial for radiotherapy to play a more active role in highly selected subpopulations. In this review, we will focus on the evolving roles of radiotherapy in advanced NSCLC. First of all, among patients who are initially unable to tolerate aggressive treatment due to severe symptoms caused by metastases and/or tumor emergencies, timely radiotherapy could significantly improve their performance status (PS) and general condition, thus giving them a chance for intensive treatment and prolonged survival. The efficacy, potential candidates, and optimal dose-fractionation regimens of radiotherapy in this clinical scenario will be discussed. Additionally, radiotherapy can play a curative role as a concurrent therapy, consolidation therapy, and salvage therapy for patients with oligo-metastatic, oligo-residual, and oligo-progressive disease, respectively. Accumulating evidence from recent clinical trials, basic research, and translational investigations regarding the potentially curative roles of radiotherapy in NSCLC patients with oligo-metastatic disease will be summarized. Moreover, with the advent of various small molecular tyrosine kinase inhibitors (TKIs), the treatment efficacy and overall survival of oncogene-addicted NSCLC with brain metastases have been significantly improved, and the clinical value and optimal timing of cranial radiotherapy have become topics of much debate. Finally, synergistic antitumor interactions between radiotherapy and immunotherapy have been repeatedly demonstrated. Thus, the immune sensitizing role of radiotherapy in advanced NSCLC is also highlighted in this review.
format Online
Article
Text
id pubmed-7815368
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-78153682021-01-22 A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player Zhou, Yue Yu, Fan Zhao, Yang Zeng, Ya Yang, Xi Chu, Li Chu, Xiao Li, Yida Zou, Liqing Guo, Tiantian Zhu, Zhengfei Ni, Jianjiao Transl Lung Cancer Res Review Article Radiotherapy, along with other loco-regional interventions, is conventionally utilized as a palliative approach to alleviate symptoms and mitigate oncological emergencies in advanced non-small cell lung cancer (NSCLC). Thanks to the ongoing improvement of medical treatments in the last decade, such as targeted therapy and immunotherapy, the survival of patients with advanced NSCLC has been considerably prolonged, making it feasible and clinically beneficial for radiotherapy to play a more active role in highly selected subpopulations. In this review, we will focus on the evolving roles of radiotherapy in advanced NSCLC. First of all, among patients who are initially unable to tolerate aggressive treatment due to severe symptoms caused by metastases and/or tumor emergencies, timely radiotherapy could significantly improve their performance status (PS) and general condition, thus giving them a chance for intensive treatment and prolonged survival. The efficacy, potential candidates, and optimal dose-fractionation regimens of radiotherapy in this clinical scenario will be discussed. Additionally, radiotherapy can play a curative role as a concurrent therapy, consolidation therapy, and salvage therapy for patients with oligo-metastatic, oligo-residual, and oligo-progressive disease, respectively. Accumulating evidence from recent clinical trials, basic research, and translational investigations regarding the potentially curative roles of radiotherapy in NSCLC patients with oligo-metastatic disease will be summarized. Moreover, with the advent of various small molecular tyrosine kinase inhibitors (TKIs), the treatment efficacy and overall survival of oncogene-addicted NSCLC with brain metastases have been significantly improved, and the clinical value and optimal timing of cranial radiotherapy have become topics of much debate. Finally, synergistic antitumor interactions between radiotherapy and immunotherapy have been repeatedly demonstrated. Thus, the immune sensitizing role of radiotherapy in advanced NSCLC is also highlighted in this review. AME Publishing Company 2020-12 /pmc/articles/PMC7815368/ /pubmed/33489808 http://dx.doi.org/10.21037/tlcr-20-1145 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Review Article
Zhou, Yue
Yu, Fan
Zhao, Yang
Zeng, Ya
Yang, Xi
Chu, Li
Chu, Xiao
Li, Yida
Zou, Liqing
Guo, Tiantian
Zhu, Zhengfei
Ni, Jianjiao
A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
title A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
title_full A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
title_fullStr A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
title_full_unstemmed A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
title_short A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
title_sort narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815368/
https://www.ncbi.nlm.nih.gov/pubmed/33489808
http://dx.doi.org/10.21037/tlcr-20-1145
work_keys_str_mv AT zhouyue anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT yufan anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT zhaoyang anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT zengya anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT yangxi anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT chuli anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT chuxiao anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT liyida anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT zouliqing anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT guotiantian anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT zhuzhengfei anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT nijianjiao anarrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT zhouyue narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT yufan narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT zhaoyang narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT zengya narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT yangxi narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT chuli narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT chuxiao narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT liyida narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT zouliqing narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT guotiantian narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT zhuzhengfei narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer
AT nijianjiao narrativereviewofevolvingrolesofradiotherapyinadvancednonsmallcelllungcancerfrompalliativecaretoactiveplayer